Jupiter Neurosciences (JUNS) Retained Earnings (2023 - 2025)
Jupiter Neurosciences (JUNS) posted quarterly Retained Earnings of -$34.7 million for Q4 2025, down 214.83% year-over-year from $30.2 million in Q4 2024, and down 8.02% quarter-over-quarter from -$32.1 million in Q3 2025.
Jupiter Neurosciences (JUNS) Retained Earnings (2023 - 2025) Analysis & Trends
Jupiter Neurosciences (JUNS) has reported Retained Earnings for 3 consecutive years, with -$34.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Retained Earnings fell 214.83% year-over-year to -$34.7 million; the TTM figure through Dec 2025 stood at -$34.7 million (down 214.83% YoY), while the FY2025 annual figure was -$34.7 million, down 214.83% from the prior year.
- Retained Earnings eased to -$34.7 million in Q4 2025 per JUNS's latest filing, from -$32.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at $31.1 million in Q2 2025 and bottomed at -$34.7 million in Q4 2025.
- Historically, Retained Earnings has averaged $2.9 million across 3 years, with a median of $18.8 million in 2024.
- Annual changes were most pronounced in 2024 — Retained Earnings surged 228.02% — and 2025, when it slumped 270.56%.
- Jupiter Neurosciences' Retained Earnings stood at -$23.6 million in 2023, then soared by 228.02% to $30.2 million in 2024, then plunged by 214.83% to -$34.7 million in 2025.
- Business Quant data shows JUNS's Retained Earnings at -$34.7 million in Q4 2025, -$32.1 million in Q3 2025, and $31.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Jupiter Neurosciences | 3.37 Mn | 1.85 Mn | 21,064.00 | -39.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -34.67 Mn |
| Sep 30, 2025 | -32.09 Mn |
| Jun 30, 2025 | 31.14 Mn |
| Mar 31, 2025 | 30.61 Mn |
| Dec 31, 2024 | 30.19 Mn |
| Sep 30, 2024 | 18.82 Mn |
| Dec 31, 2023 | -23.58 Mn |